Kocogulları Cevdet Ugur, Kunt Atike Tekeli, Aksoy Rezan, Duzyol Cagrı, Parlar Hakan, Saskın Huseyin, Fındık Orhan
Siyami Ersek Training and Research Hospital, Istanbul, Turkey.
Derince Training and Research Hospital, Kocaeli, Turkey.
Braz J Cardiovasc Surg. 2017 Mar-Apr;32(2):83-89. doi: 10.21470/1678-9741-2016-0010.
: Elevated hemoglobin A1c levels in patients with diabetes mellitus have been known as a risk factor for acute kidney injury after coronary artery bypass grafting. However, the relationship between hemoglobin A1c levels in non-diabetics and acute kidney injury is under debate. We aimed to investigate the association of preoperative hemoglobin A1c levels with acute kidney injury in non-diabetic patients undergoing isolated coronary artery bypass grafting.
: 202 non-diabetic patients with normal renal function (serum creatinine <1.4 mg/dl) who underwent isolated coronary bypass were analyzed. Hemoglobin A1c level was measured at the baseline examination. Patients were separated into two groups according to preoperative Hemoglobin A1c level. Group 1 consisted of patients with preoperative HbA1c levels of < 5.6% and Group 2 consisted of patients with preoperative HbA1c levels of ≥ 5.6%. Acute kidney injury diagnosis was made by comparing baseline and postoperative serum creatinine to determine the presence of predefined significant change based on the Kidney Disease Improving Global Outcomes (KDIGO) definition.
: Acute kidney injury occurred in 19 (10.5%) patients after surgery. The incidence of acute kidney injury was 3.6% in Group 1 and 16.7% in Group 2. Elevated baseline hemoglobin A1c level was found to be associated with acute kidney injury (P=0.0001). None of the patients became hemodialysis dependent. The cut off value for acute kidney injury in our group of patients was 5.75%.
: Our findings suggest that, in non-diabetics, elevated preoperative hemoglobin A1c level may be associated with acute kidney injury in patients undergoing coronary artery bypass grafting. Prospective randomized studies in larger groups are needed to confirm these results.
糖尿病患者血红蛋白A1c水平升高一直被认为是冠状动脉搭桥术后急性肾损伤的危险因素。然而,非糖尿病患者血红蛋白A1c水平与急性肾损伤之间的关系仍存在争议。我们旨在研究单纯冠状动脉搭桥术的非糖尿病患者术前血红蛋白A1c水平与急性肾损伤之间的关联。
分析202例肾功能正常(血清肌酐<1.4mg/dl)的非糖尿病患者,这些患者接受了单纯冠状动脉搭桥术。在基线检查时测量血红蛋白A1c水平。根据术前血红蛋白A1c水平将患者分为两组。第1组由术前HbA1c水平<5.6%的患者组成,第2组由术前HbA1c水平≥5.6%的患者组成。通过比较基线和术后血清肌酐,根据改善全球肾脏病预后组织(KDIGO)的定义确定是否存在预先定义的显著变化,从而做出急性肾损伤的诊断。
术后19例(10.5%)患者发生急性肾损伤。第1组急性肾损伤发生率为3.6%,第2组为16.7%。发现基线血红蛋白A1c水平升高与急性肾损伤相关(P=0.0001)。没有患者依赖血液透析。我们这组患者急性肾损伤的临界值为5.75%。
我们的研究结果表明,在非糖尿病患者中,术前血红蛋白A1c水平升高可能与冠状动脉搭桥术患者的急性肾损伤有关。需要在更大规模的前瞻性随机研究中证实这些结果。